Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 1 390 IDR 4.51% Market Closed
Market Cap: 65.2T IDR
Have any thoughts about
Kalbe Farma Tbk PT?
Write Note

Kalbe Farma Tbk PT
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kalbe Farma Tbk PT
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Kalbe Farma Tbk PT
IDX:KLBF
Cash from Operating Activities
Rp5T
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
10%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Cash from Operating Activities
Rp1.5T
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
15%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Cash from Operating Activities
Rp319.7B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Soho Global Health Tbk PT
IDX:SOHO
Cash from Operating Activities
Rp211.1B
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Cash from Operating Activities
Rp96.5B
CAGR 3-Years
N/A
CAGR 5-Years
46%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Cash from Operating Activities
Rp582.4B
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
9%
No Stocks Found

Kalbe Farma Tbk PT
Glance View

Market Cap
64.1T IDR
Industry
Pharmaceuticals

Kalbe Farma Tbk PT is a renowned pharmaceutical powerhouse rooted in Indonesia, rooted in a rich history that traces back to 1966. The company has evolved from a humble startup into a multifaceted entity with a robust portfolio, making it a vital player in the health and wellness sector across Southeast Asia. The company operates across four main business divisions: prescription pharmaceuticals, consumer health products, nutritionals, and distribution & logistics. By strategically linking these divisions, Kalbe Farma masterfully balances scientific innovation with market accessibility, ensuring a wide reach and varied product offering. This diversification not only broadens its revenue streams but also mitigates risk, securing its foothold in the competitive pharmaceutical landscape. At the core of Kalbe Farma’s business model lies a commitment to research and development, which fuels its cutting-edge product innovations and enhances its competitive edge. The company dedicates substantial resources to developing new medicines and health products, constantly seeking to address emerging health concerns. Moreover, its extensive distribution network fortifies its market presence, comprising a domestic distribution arm that penetrates even the farthest reaches of the Indonesian archipelago. This network ensures that Kalbe's products are widely available, amplifying their market penetration and revenue. Additionally, Kalbe embraces partnerships and collaborations to enhance its research capabilities and expand its product offerings, fostering an ecosystem where innovation and accessibility coexist harmoniously, thereby empowering its bottom line.

KLBF Intrinsic Value
1 428.28 IDR
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Kalbe Farma Tbk PT's Cash from Operating Activities?
Cash from Operating Activities
5T IDR

Based on the financial report for Sep 30, 2024, Kalbe Farma Tbk PT's Cash from Operating Activities amounts to 5T IDR.

What is Kalbe Farma Tbk PT's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%

Over the last year, the Cash from Operating Activities growth was 128%. The average annual Cash from Operating Activities growth rates for Kalbe Farma Tbk PT have been 7% over the past three years , 15% over the past five years , and 10% over the past ten years .

Back to Top